Go Pro
OTCMKTS:AOBI

American Oriental Bioengineering (AOBI) Stock Price, News & Analysis

$0.01 0.00 (0.00%)
As of 09/11/2026

About American Oriental Bioengineering Stock (OTCMKTS:AOBI)

Advanced

Key Stats

Today's Range
$0.0130
$0.0130
50-Day Range
$0.0012
$0.0130
52-Week Range
$0.0011
$0.0130
Volume
N/A
Average Volume
0 shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

American Oriental Bioengineering Inc (OTCMKTS:AOBI) is a biotechnology company specializing in the research, development and manufacturing of recombinant human type I collagen. The company’s proprietary fermentation-based production process yields high-purity, biocompatible collagen that serves as the basis for a range of wound care, cosmetic and biomedical applications.

American Oriental Bioengineering’s product portfolio includes advanced wound-healing dressings, dermal fillers, oral care formulations and tissue-engineering scaffolds. Through partnerships with pharmaceutical and medical device firms as well as cosmetics manufacturers, its collagen materials are incorporated into products designed to accelerate tissue repair, enhance skin regeneration and support regenerative medicine therapies.

Headquartered in China, the company operates research and production facilities that supply markets in Asia, Europe and North America via direct sales and distributor networks. With ongoing investment in research and development and collaborations with academic institutions and industry partners, American Oriental Bioengineering is pursuing expanded applications in orthopedics, aesthetic medicine and other emerging areas of regenerative health care.

AI Generated. May Contain Errors.

Receive AOBI Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for American Oriental Bioengineering and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

AOBI Stock News Headlines

American Oriental Bioengineering
What is Elon Building in Texas?
Elon Musk's latest Texas project is massive - three times the size of Central Park and backed by a reported 122 billion dollar price tag. The build could double American chip production, but it is not Tesla or SpaceX driving it. One lesser-known company sits at the center of the entire operation. Get the name and ticker behind this Texas mega-project.tc pixel
American Oriental Bioengineering, Inc. (AOBI)
See More Headlines

AOBI Stock Analysis - Frequently Asked Questions

American Oriental Bioengineering's stock was trading at $0.0012 at the start of the year. Since then, AOBI stock has increased by 983.3% and is now trading at $0.0130.

Shares of AOBI stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that American Oriental Bioengineering investors own include Armata Pharmaceuticals (ARMP), Aurora Cannabis (ACB), ACADIA Pharmaceuticals (ACAD), Arbutus Biopharma (ABUS), Advanced Biomedical Technologies (ABMT) and

Company Calendar

Today
9/14/2026
Fiscal Year End
12/31/2026

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Industry
Pharmaceuticals
Sub-Industry
Pharmaceuticals
Current Symbol
OTCMKTS:AOBI
Previous Symbol
NYSE:AOB
CIK
N/A
Employees
3,720
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
N/A
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
N/A

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
N/A
Quick Ratio
N/A

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
N/A
Price / Book
N/A

Miscellaneous

Outstanding Shares
N/A
Free Float
N/A
Market Cap
N/A
Optionable
Not Optionable
Beta
1.60
The Infrastructure's Backbone: 10 Stocks Powering the AI Buildout Cover

The AI boom extends far beyond the biggest tech names. Discover 10 companies supplying the memory, storage, networking, semiconductor manufacturing, and power infrastructure that make AI possible. Learn where the next wave of AI investment opportunities may emerge—and the key risks investors should watch as the global AI buildout accelerates.

Get This Free Report

This page (OTCMKTS:AOBI) was last updated on 9/14/2026 by MarketBeat.com Staff.
From Our Partners